{"meta":{"query_hash":"6eb7f29437b7","filters":{"venue":"Prostate International"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6eb7f29437b7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Prostate+International"},"results":[{"id":"W2792049128","doi":"10.1016/j.prnil.2018.03.002","title":"Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?","year":2018,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Prostate-specific antigen; Pathological; Receiver operating characteristic; Adverse effect; Cancer; Cohort; Oncology; Internal medicine; Urology; Cutoff","score_opus":0.034589263984855505,"score_gpt":0.3346653812258444,"score_spread":0.30007611724098887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792049128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629545,0.00061111077,0.0000052910113,0.03242909,0.00055966614,0.0028929734,0.00034371344,0.00002057799,0.00018306376],"genre_scores_gemma":[0.9920651,0.0034609553,0.000108320564,0.0027844657,0.00022703288,0.0008107855,0.00040878012,0.000031292388,0.000103273844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981144,0.000091590744,0.0004233081,0.00051515223,0.0004678402,0.00038769617],"domain_scores_gemma":[0.99888456,0.00018000176,0.00022901467,0.00020172106,0.0004445427,0.000060148413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047746056,0.00024121377,0.0002705582,0.00014146273,0.00020838047,0.00027231485,0.00016899474,0.00006181105,0.000032162236],"category_scores_gemma":[0.00007687674,0.00015444042,0.000060110837,0.00031297657,0.0001395554,0.00064375735,0.00007716499,0.0002437882,0.0000029957846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011399215,0.00027524252,0.9291793,0.000037067715,0.000094428025,0.00000895589,0.013820645,0.000008505893,0.000082540566,0.000055104963,0.0014378122,0.053860445],"study_design_scores_gemma":[0.0030100243,0.00041286077,0.9801628,0.0002716668,0.000016530048,0.00000876571,0.0018753948,0.0005445858,0.0022845995,0.0007172376,0.010520288,0.00017521973],"about_ca_topic_score_codex":0.0010608478,"about_ca_topic_score_gemma":0.0029967476,"teacher_disagreement_score":0.053685226,"about_ca_system_score_codex":0.0004034262,"about_ca_system_score_gemma":0.00009865032,"threshold_uncertainty_score":0.62978977},"labels":[],"label_agreement":null},{"id":"W4210316818","doi":"10.1016/j.prnil.2022.01.004","title":"Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer","year":2022,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Logistic regression; Prostate biopsy; Core (optical fiber); Cancer; Stage (stratigraphy); Core biopsy; Internal medicine; Surgery; Urology; Breast cancer","score_opus":0.01860648074195801,"score_gpt":0.29249639592186844,"score_spread":0.2738899151799104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210316818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915338,0.0012934671,0.0000057387524,0.0027982737,0.0010477711,0.0007840188,0.0017508833,0.00004234413,0.0007436626],"genre_scores_gemma":[0.99534345,0.0014732282,0.0001618855,0.00048221907,0.000089550966,0.0009921392,0.0005130292,0.000030178411,0.0009143454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985751,0.000039160746,0.0003153805,0.00041981452,0.00036987342,0.0002806909],"domain_scores_gemma":[0.99942166,0.00007004989,0.00017068112,0.00011467966,0.000111120826,0.00011180414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018179616,0.00018336465,0.0002299145,0.0002517865,0.00012595393,0.00004921277,0.00009514591,0.000027200575,0.0004338565],"category_scores_gemma":[0.000045843983,0.00016886737,0.000057812176,0.00019648661,0.00008981196,0.00014394078,0.00021445325,0.0003119016,0.000007106783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010648435,0.0004642507,0.94066745,0.00003182588,0.00020685475,0.00033775088,0.0050587025,0.00012575577,0.0021749616,0.0002334878,0.0007628943,0.048871197],"study_design_scores_gemma":[0.009596231,0.0017101684,0.9599923,0.00042927236,0.00012357252,0.00036086276,0.0018374933,0.0023993792,0.0058099376,0.0017072735,0.01556939,0.00046411078],"about_ca_topic_score_codex":0.0007645504,"about_ca_topic_score_gemma":0.000097765784,"teacher_disagreement_score":0.048407085,"about_ca_system_score_codex":0.0009119877,"about_ca_system_score_gemma":0.00012076614,"threshold_uncertainty_score":0.6886211},"labels":[],"label_agreement":null},{"id":"W4389266080","doi":"10.1016/j.prnil.2023.11.004","title":"Risks and side effects in the medical management of benign prostatic hyperplasia","year":2023,"lang":"en","type":"review","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Desmopressin; Side effect (computer science); Pharmacotherapy; Lower urinary tract symptoms; Hyperplasia; Urology; Intensive care medicine; Quality of life (healthcare); cGMP-specific phosphodiesterase type 5; Gynecology; Internal medicine; Erectile dysfunction; Prostate","score_opus":0.1233222919365214,"score_gpt":0.4559810165591553,"score_spread":0.3326587246226339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389266080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047873138,0.98368615,0.000012479271,0.0008989842,0.00026194932,0.0039013978,0.00011835301,0.00003687529,0.010605084],"genre_scores_gemma":[0.00081170734,0.99645114,0.00019418172,0.000058406975,0.000084372194,0.0007085177,0.00036158672,0.000048216745,0.0012818971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698067,0.00024850856,0.00068062375,0.0003897514,0.0013959885,0.00030444723],"domain_scores_gemma":[0.9985266,0.0008527858,0.00016383493,0.0002601898,0.000079676174,0.000116911484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013283119,0.00026753292,0.00080711476,0.00040500882,0.000035768455,0.000041690448,0.0003798256,0.00015224605,0.000047856844],"category_scores_gemma":[0.00021341554,0.00016458162,0.00016294022,0.0004025485,0.00015707676,0.000055524724,0.000275552,0.0007020941,0.000077877725],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085641266,0.00020244339,0.00025450988,0.05620734,0.0006461334,0.0033202365,0.0004029903,3.2818747e-7,1.804585e-7,0.0013233898,0.0002495596,0.93730724],"study_design_scores_gemma":[0.0026963616,0.00071266224,0.004591772,0.06593501,0.000868578,0.0020764503,0.00034127032,0.00022116589,0.000002917851,0.0019319853,0.9202547,0.00036712558],"about_ca_topic_score_codex":0.00005711612,"about_ca_topic_score_gemma":0.000010991377,"teacher_disagreement_score":0.93694013,"about_ca_system_score_codex":0.000082749364,"about_ca_system_score_gemma":0.00025896658,"threshold_uncertainty_score":0.67114437},"labels":[],"label_agreement":null},{"id":"W4389688076","doi":"10.1016/j.prnil.2023.12.001","title":"High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group","year":2023,"lang":"en","type":"article","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Enucleation; Prostate; Lower urinary tract symptoms; Urology; International Prostate Symptom Score; Urinary retention; Surgery; Bladder outlet obstruction; Prostate cancer; Transurethral resection of the prostate; Odds ratio; Internal medicine; Cancer","score_opus":0.01741993864668499,"score_gpt":0.2813165768339399,"score_spread":0.2638966381872549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389688076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878072,0.000018944802,0.0000053136414,0.003450447,0.0008925571,0.0049435734,0.0023893735,0.0000763367,0.00041625783],"genre_scores_gemma":[0.99290556,0.00004424141,0.00013680484,0.0001162905,0.00015983974,0.00058132876,0.0032424903,0.00007671653,0.0027367594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667907,0.00022982861,0.0006988781,0.0006349908,0.0012352447,0.00052197545],"domain_scores_gemma":[0.9978765,0.0005992078,0.00032550743,0.0005521856,0.00055374287,0.000092857306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077796605,0.00031398603,0.0003371652,0.00023724021,0.0002014353,0.00011585343,0.00039331362,0.00009140185,0.0001895848],"category_scores_gemma":[0.00035258182,0.00018826246,0.0001051486,0.0006258723,0.00015050411,0.00037834534,0.00024612268,0.00041819573,0.00007065198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027794817,0.0014124382,0.95393795,0.00007317734,0.0005021528,0.000026497844,0.009804449,0.00035731462,0.00030004367,0.00003524476,0.0039631836,0.0017927055],"study_design_scores_gemma":[0.03099554,0.0030943044,0.9573871,0.00022172806,0.00008926561,7.1363525e-7,0.00086301233,0.00029593564,0.002487146,0.00019737676,0.0041857962,0.00018210859],"about_ca_topic_score_codex":0.0006271606,"about_ca_topic_score_gemma":0.00041833665,"teacher_disagreement_score":0.008941436,"about_ca_system_score_codex":0.00018822066,"about_ca_system_score_gemma":0.00016760065,"threshold_uncertainty_score":0.76771206},"labels":[],"label_agreement":null},{"id":"W4404367273","doi":"10.1016/j.prnil.2024.11.001","title":"Concurrent antiandrogen therapy in the salvage radiotherapy setting for recurrent prostate cancer: a literature review","year":2024,"lang":"en","type":"review","venue":"Prostate International","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salvage therapy; Prostate cancer; Radiation therapy; Antiandrogen; Recurrent prostate cancer; Prostatectomy; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.06130048351684187,"score_gpt":0.45614122306571303,"score_spread":0.39484073954887117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404367273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010942681,0.97487354,0.00000439791,0.009625547,0.0015162282,0.011064147,0.002680608,0.00006020213,0.0001643898],"genre_scores_gemma":[0.000007502804,0.9821549,0.000084281055,0.0010112703,0.00085622224,0.008746653,0.004845108,0.00011657332,0.002177482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967245,0.00023433997,0.0009464051,0.00079427345,0.00075491564,0.0005455703],"domain_scores_gemma":[0.9986644,0.00020504941,0.00034154663,0.00035872494,0.0003242377,0.00010603907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001099089,0.00063385407,0.0013692979,0.00040368692,0.00008421344,0.00028546865,0.00051948655,0.00018254807,0.000104783845],"category_scores_gemma":[0.00006785214,0.00032721885,0.00083433563,0.0007234823,0.00009348741,0.00012735932,0.00007068605,0.0010829109,0.000023654406],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486091,0.00017050833,0.000040316692,0.06655311,0.0009305359,0.00024305789,0.001155604,1.0697854e-7,0.0000015306344,0.00006718637,0.030065449,0.9006177],"study_design_scores_gemma":[0.0015199501,0.00039076718,0.000004731576,0.20197567,0.00046845182,0.00021548214,0.000016159538,0.000043455773,0.00000367447,0.000041533087,0.7950664,0.00025369687],"about_ca_topic_score_codex":0.000009412728,"about_ca_topic_score_gemma":0.0000073512924,"teacher_disagreement_score":0.90036404,"about_ca_system_score_codex":0.0007058453,"about_ca_system_score_gemma":0.0009765178,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W4412435884","doi":"10.1016/j.prnil.2025.07.002","title":"Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Modalities; Treatment modality; Medical physics; Current (fluid); Therapeutic modalities; Cancer; Intensive care medicine; Internal medicine","score_opus":0.013600582574124758,"score_gpt":0.350079016046935,"score_spread":0.3364784334728102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412435884","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53496885,0.3336551,0.0002634332,0.11012013,0.0081066955,0.006146435,0.0022260004,0.00021150209,0.0043018796],"genre_scores_gemma":[0.42430755,0.5650016,0.00051450875,0.0011599442,0.000384471,0.0057522035,0.00039647226,0.000028217428,0.0024550264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990428,0.000013524852,0.00026855516,0.00031223125,0.00015869277,0.00020416145],"domain_scores_gemma":[0.9995464,0.00007131577,0.000066158726,0.00009880737,0.00015985241,0.000057483143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008847347,0.00016205807,0.00023441091,0.00017742357,0.000066105335,0.000041277624,0.00005780146,0.000036094978,0.000035870413],"category_scores_gemma":[0.00001880275,0.00012535525,0.00006956491,0.0001287871,0.00005311366,0.0001809684,0.000029641884,0.00012034966,9.175043e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039667197,0.00025844813,0.41008776,0.00007664335,0.00008196537,0.0000028440006,0.00036933823,0.000007508346,0.000010168747,0.002799338,0.00055627647,0.585353],"study_design_scores_gemma":[0.0045198896,0.00013231016,0.2131655,0.00021639222,0.000023399869,0.0000025008428,0.00011588663,0.00028293426,0.00035527674,0.0036474438,0.7774363,0.000102154154],"about_ca_topic_score_codex":0.00013249708,"about_ca_topic_score_gemma":0.00022045005,"teacher_disagreement_score":0.77688,"about_ca_system_score_codex":0.0003180145,"about_ca_system_score_gemma":0.00019491125,"threshold_uncertainty_score":0.51118386},"labels":[],"label_agreement":null},{"id":"W4415751873","doi":"10.1016/j.prnil.2025.10.002","title":"Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; BP (Canada); University of Toronto","funders":"","keywords":"Quality of life (healthcare); Logistic regression; Pooled analysis; Sexual function; Clinical trial; International Prostate Symptom Score; Psychological intervention; Prostate cancer","score_opus":0.07965961175546782,"score_gpt":0.46366481750524313,"score_spread":0.3840052057497753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415751873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753345,0.00035294946,0.000475434,0.0035040001,0.00018863467,0.00045539383,0.00027122532,0.0000148561785,0.0072040474],"genre_scores_gemma":[0.99733865,0.00014775209,0.00059533806,0.00015318028,0.000022713552,0.000044101842,0.00037044534,0.0000100548,0.0013177715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684596,0.00023536425,0.0013447695,0.00029753044,0.0010988235,0.00017758146],"domain_scores_gemma":[0.9974063,0.0008661192,0.0004880424,0.00019769622,0.00097532663,0.0000664928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015303127,0.00016377137,0.00090607756,0.0013033195,0.000028753833,0.000014265745,0.00022835763,0.00006290444,0.00013371915],"category_scores_gemma":[0.0020993403,0.00013287061,0.00028062076,0.0008744561,0.00015917352,0.00022203167,0.0001640546,0.00019475006,0.0000015219898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003929582,0.00050963345,0.97158104,0.00027384574,0.015786285,0.0000081365715,0.0025175395,0.0006995799,0.0018863117,0.0015845685,0.000099053774,0.0011243973],"study_design_scores_gemma":[0.00546145,0.00018347755,0.9847987,0.00020443999,0.00042687648,2.944214e-7,0.0030993607,0.0028208913,0.0021530036,0.0006705566,0.000057241457,0.00012366241],"about_ca_topic_score_codex":0.0013221136,"about_ca_topic_score_gemma":0.00031439803,"teacher_disagreement_score":0.015359407,"about_ca_system_score_codex":0.00014681669,"about_ca_system_score_gemma":0.00043352673,"threshold_uncertainty_score":0.5418306},"labels":[],"label_agreement":null},{"id":"W4416021469","doi":"10.1016/j.prnil.2025.11.001","title":"Irreversible electroporation in focal therapy for prostate cancer: current status and future directions","year":2025,"lang":"en","type":"article","venue":"Prostate International","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; NOSM University; McGill University Health Centre","funders":"","keywords":"Irreversible electroporation; Prostate cancer; Prostate; Ablative case; Neurovascular bundle; Prostatectomy; Ablation; Erectile function","score_opus":0.010312474473598201,"score_gpt":0.34201841837900976,"score_spread":0.3317059439054116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416021469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97529155,0.008878448,0.0074630515,0.005115403,0.0014210674,0.0010997171,0.00023318693,0.000023961971,0.00047360832],"genre_scores_gemma":[0.84983915,0.12505756,0.010844132,0.0011463469,0.0014152833,0.0015059466,0.0033582067,0.000054424214,0.006778965],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993683,0.00003738245,0.00015441878,0.0002381485,0.000057837427,0.00014387461],"domain_scores_gemma":[0.9996638,0.0000116789115,0.000061260216,0.00006861525,0.00017134837,0.000023302517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001381336,0.000088426284,0.000070909606,0.00010846703,0.000056238652,0.000038052138,0.00006152257,0.00005127438,0.000018014898],"category_scores_gemma":[0.000036046647,0.00008783301,0.000029119701,0.00011675636,0.000028375525,0.000012938383,0.000030881783,0.00007949432,3.625719e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078261754,0.00013781425,0.03656378,0.000031083997,0.000076223085,2.039866e-7,0.0002669849,0.00005178523,0.48433015,0.0019306724,0.007121423,0.46870726],"study_design_scores_gemma":[0.0009810003,0.00006858417,0.011238938,0.00001026186,0.000003466838,6.3007565e-7,0.0000485426,0.00022902605,0.1329475,0.0009859337,0.8533986,0.00008750019],"about_ca_topic_score_codex":0.000063828375,"about_ca_topic_score_gemma":0.00016310524,"teacher_disagreement_score":0.8462772,"about_ca_system_score_codex":0.000079590754,"about_ca_system_score_gemma":0.00014920598,"threshold_uncertainty_score":0.35817263},"labels":[],"label_agreement":null}]}